RTCT raises hard questions about sponsor liability, blinding integrity, DSMB overlap, and AI accountability that the industry hasn’t yet resolved. Both sides of that ledger deserve honest consideration.
- Pharma's Digital Transformation: Where It's Really At
- How AI Is Changing Clinical Trial Design, Not Just Speed
- What Is Clinical Trials Day? Why Technology Helps Research Rise
- DiMe's Navigator: Why Teams Still Stall On Digital Endpoints
- Why Are Life Science Companies So Poorly Prepared For RIM's Future?
- Digital Endpoints Are Ready. Clinical Development Isn't
- Why Clinical Trial Data Cleaning Must Go Continuous (And How To Do It)
- What Clinical Analytics Solutions Are Shaping Clinical Research
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
How EDC-Based SAE Reporting Reduces Time To Detection And Response
Serious adverse events (SAEs) play a pivotal role in patient safety during clinical trials, and the right EDC system helps you efficiently track and manage the entire lifecycle of SAE reporting.
-
5 Key Considerations For Implementing Digital Technologies To Support Patients In China
In this post, gain insight into five key considerations that will help support patients in China.
-
Tech And Strategies For Reaching Underserved Patient Populations
By leveraging flexible solutions, learn how sponsors can proactively address regulatory mandates while advancing the development of safer and more effective therapies for a broader spectrum of patients.
-
7 Key Findings From A Clinical Trial Operations Technology Survey
To stay competitive in the clinical research field, sites, sponsors, and CROs need to invest in remote technology. Discover seven key trends that your clinical trial team needs to know about.
-
Empowering Clinical Trial Sponsors With Analytics
Explore data challenges faced by sponsors, the underlying problems driving those challenges, and flexible processes and solutions designed to help overcome them.
-
Simplifying The Regulatory Submission Process With A Modern CTMS
Working in collaboration with industry representatives, explore the value that pulling the regulatory submission process into a modern Clinical Trial Management System (CTMS) could have.
-
Setting A New Client Standard In Study Closeout Timelines
Learn how a top-10 global pharmaceutical company achieved a significantly faster time to market for a high-profile therapy.
-
Tackling Feasibility In Rare Disease Clinical Trials
Rare disease clinical trials face distinct challenges, but the right data strategy can offer a transformative approach to addressing complexities and enhancing enrollment.
-
Kicking Off A Clinical Trial The Right Way - With Seamless Digital Consent
Read this blog to learn more about how eConsent can enhance participant engagement and retention when used both onsite and remotely.
-
Discover Why Electronic Revisions Of ICFs Are Easier
What does the ICF amendment or revision process look like within a digital platform and is this harder or easier than traditional paper-based approaches?
RECENT NEWSLETTERS
- 05.28.26 -- FDA's Elsa AI Shift, RTCT Rules, And RWE That Works
- 05.21.26 -- AI, HEOR, And Hidden Costs Reshaping Clinical Trials
- 05.14.26 -- AI, RWE, And The Systems Breaking Clinical Trials
- 05.07.26 -- How AI, ICH E6(R3) & RWD Are Reshaping Clinical Trials
- 05.02.26 -- Best Of April: AI In Clinical Trials — What Working